以分泌性中耳炎伴进行性听力下降为首发症状的ANCA相关性血管炎一例
寿铸;何丹;
1:重庆市渝北区人民医院耳鼻咽喉科
2:重庆市人民医院耳鼻咽喉头颈外科
摘要关键词基金项目(Foundation):作者参考文献1 Jennette JC,Falk RJ,Bacon PA,et al.2012revised international chapel hill consensus conference nomenclature of vasculitides[J].Arthritis Rheum,2013,65(1):1-11．
2 Katsuyama T,Sada KE,Makino H.Current concept and epidemiology ofsystemic vasculitides[J].Allergol Int,2014,63(4):505-513．
3 Sada KE,Yamamura M,Harigai M,et al.Classification andcharacteristics of Japanese patients with antineutrophil cytoplasmicantibody-associated vasculitis in a nationwide,prospective,inception cohort study[J].Arthritis Res Ther,2014,16(2):R101-R101．
4 Yoshida N,Kishibe K,Tateyama K,et al.Clinical features of90cases of otitis media with ANCA associated vasculitis[J].Otol Jpn,2014,24(1):53-61．
5 Yoshida N,Iino Y.Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis[J].Allergol Int,2014,63(4):523-532．
6 Harabuchi Y,Kishibe K,Tateyama K,et al.Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis(OMAAV):a retrospective analysis of 235patients from a nationwide survey in Japan[J].Mod Rheumatol,2017,27(1):87-94．
7 Cohen Tervaert JW,Damoiseaux J.Antineutrophil cytoplasmic autoantibodies:how are they detected and what is their use for diagnosis,classification and follow-up[J]?Clin Rev Allergy Immunol,2012,43(3):211-219．
8 Morita S,Nakamaru Y,Nakazawa D,et al.The diagnostic and clinical utility of the myeloperoxidase-DNA complex as a biomarker in otitis media with antineutrophil cytoplasmic antibody-associated vasculitis[J].Otol Neurotol,2019,40(2):e99-e106．
9郝香月，郑茵，易英，等．以分泌性中耳炎为首发症状的肉芽肿性多血管炎的临床分析[J]．听力学及言语疾病杂志，2019,27(4):434-437．
10 Lutalo PM,D'cruz DP.Biological drugs in ANCA-associated vasculitis[J].Int Immunopharmacol,2015,27(2):209-212．
11 Harabuchi Y,Kishibe K,Tateyama K,et al.Clinical characteristics,the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody(ANCA)-associated vasculitis(OMAAV)proposed by Japan Otological Society[J].Auris Nasus Larynx,2021,48(1):2-14．
12 Yoshida N,Hara M,Hasegawa M,et al.Reversible cochlear function with ANCA-associated vasculitis initially diagnosed by otologic symptoms[J].Otol Neurotol,2014,35(1):114-120．
13 Morita Y,Kitazawa M,Yagi C,et al.Tympanic membrane findings of otitis media with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV)[J].Auris Nasus Larynx,2020,47(5):740-746.